Brown Forman vs Boston Beer
BF.B and SAM side by side, both in beverages. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BF.B and SAM compare
Brown Forman is the larger company, worth 6.2 times as much as Boston Beer ($12.9B against $2.1B).
Brown Forman grew revenue faster over the last twelve months (−0.84% versus −6.1% for Boston Beer).
Brown Forman keeps more of each dollar of sales as profit, with a net margin of 18.4% compared with −3.6% at Boston Beer.
Brown Forman pays a dividend yielding 3.3%; Boston Beer does not pay one.
Brown Forman scores higher on the StockData Score (18 against 11 for Boston Beer), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BF.B | SAM |
|---|---|---|
| Size and price | ||
| Market cap | $12.9B | $2.1B |
| Share price | $28.04 | $201.31 |
| Change, 1 year | −0.64% | −5.5% |
| Change, 5 years | −61.4% | −60.0% |
| Beta (5Y) | 0.59 | 0.76 |
| Employees | 4,900 | 2,543 |
| StockData Score | ||
| Total score | 18 (better) | 11 |
| Valuation score | 5 (better) | 3 |
| Growth score | 1 | 2 (better) |
| Performance score | 4 (better) | 0 |
| Health score | 5 | 6 (better) |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 18.1× | – |
| P/S | 3.3× | 1.1× (better) |
| P/B | 3.2× | 2.9× (better) |
| EV/EBITDA | 13.8× | – |
| P/FCF | 13.9× | 10.1× (better) |
| FCF yield | 7.2% | 9.9% (better) |
| Fair value | $36.93 | $258.25 |
| Margin of safety | 24.1% (better) | 22.0% |
| Growth | ||
| Revenue growth (TTM) | −0.84% (better) | −6.1% |
| Revenue growth, 5Y average | 2.6% (better) | 2.5% |
| Net income growth (TTM) | −14.6% (better) | −188% |
| EPS growth (TTM) | −13.4% (better) | −196% |
| EPS growth, 5Y average | −4.0% (better) | −8.6% |
| Profitability | ||
| Gross margin | 60.7% (better) | 48.9% |
| Operating margin | 25.4% (better) | −4.7% |
| Net margin | 18.4% (better) | −3.6% |
| FCF margin | 23.6% (better) | 10.7% |
| Return on equity | 18.1% (better) | −8.6% |
| Return on invested capital | 13.0% (better) | −12.5% |
| Financial health | ||
| Debt / equity | 0.62 (better) | 0.00 |
| Net debt / EBITDA | 1.97 | – |
| Interest coverage | 9.6× | – |
| Current ratio | 3.26 (better) | 1.05 |
| Altman Z-score | 4.23 (better) | 3.62 |
| Piotroski F-score | 6 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 3.3% | – |
| Payout ratio | 59.1% | – |
| Years of dividend growth | 3 | – |
| Dividend growth, 5Y average | 5.3% | – |
| Buyback yield | – | 7.3% |
| Shareholder yield | 3.3% | 7.3% (better) |
| Ownership | ||
| Held by institutions | 47.6% | 84.0% |
| Held by insiders | 25.2% | 25.7% |
| Insider net buying, 12 months | −$1.5M | −$642K (better) |
| Superinvestors holding | 3 (better) | 1 |
| Short interest, % of float | – | 20.8% |
Go deeper
- BF.B stock overview
- BF.B income statement
- BF.B valuation and score
- SAM stock overview
- SAM income statement
- SAM valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.